Trials / Completed
CompletedNCT00912145
To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 2 mg
Bioavailability of Alprazolam Tablets, 2 mg.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Sandoz · Industry
- Sex
- Male
- Age
- 19 Years – 49 Years
- Healthy volunteers
- Accepted
Summary
To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 2 mg.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Alprazolam Tablets, 2 mg (Geneva Pharmaceuticals, Inc.) |
Timeline
- Start date
- 1996-02-01
- Primary completion
- 1996-02-01
- Completion
- 1996-02-01
- First posted
- 2009-06-03
- Last updated
- 2017-03-28
Source: ClinicalTrials.gov record NCT00912145. Inclusion in this directory is not an endorsement.